Innoviva Specialty Therapeutics
Develops therapies for critical care and infectious diseases.
Company facts
- Founded
- 2022
- Employees
- 96
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: INVA
- Subsidiaries
- La Jolla Pharmaceutical Company, Entasis Therapeutics